HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea · Delayed Price · Currency is KRW 4,200.00
+50.00 (1.20%)
At close: Jan 23, 2026
HYUNDAI BIOLAND Market Cap
HYUNDAI BIOLAND has a market cap or net worth of 126 billion as of January 23, 2026. Its market cap has decreased by -0.47% in one year.
Market Cap
126.00B
Enterprise Value
114.72B
Revenue
129.68B
Ranking
n/a
PE Ratio
10.13
Stock Price
4,200.00
Market Cap Chart
Since March 1, 2002, HYUNDAI BIOLAND's market cap has increased from 25.40B to 126.00B, an increase of 396.00%. That is a compound annual growth rate of 6.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 126.00B | -2.21% |
| Dec 30, 2025 | 128.85B | -4.87% |
| Dec 30, 2024 | 135.45B | -9.52% |
| Dec 28, 2023 | 149.70B | -25.80% |
| Dec 29, 2022 | 201.75B | -21.80% |
| Dec 30, 2021 | 258.00B | -29.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GREEN CROSS WellBeing | 164.50B |
| Kyung Dong Pharmaceutical | 152.76B |
| PHARMARESEARCH BIO | 147.16B |
| DongKoo Bio & Pharma | 140.08B |
| KOREA PHARMA | 137.86B |
| OPTUS Pharmaceutical | 133.76B |
| Pharos iBio | 127.78B |
| High Tech Pharm | 122.71B |